Focus on Fabry is a resource for patients, families and healthcare professionals with an interest in
Fabry disease. Fabry disease is a rare genetic disorder that causes a wide range of symptoms due
to abnormal deposits of a fatty substance (called globotriaosylceramide) in the cells of the body.
This site is intended for use by residents of the United Kingdom only.
Please enter the site most relevant to you.
The information on this website is intended only to provide knowledge of Fabry disease health topics. This information should not be used in place of advice from your GP or other healthcare professional.
The Focus on Fabry website is intended for residents of the United Kingdom only. Focus on Fabry has been produced by Shire Human Genetic Therapies, a business unit
of Shire Pharmaceuticals Group Ltd. The website has been developed in accordance with industry and legal standards to provide information for the general public, patients and their families, and also healthcare professionals about Fabry disease health topics. Shire Human Genetic Therapies makes every reasonable effort to include accurate and current information. However, the information provided on the website is not exhaustive. References for published sources of information cited on the Focus on Fabry website have been provided on the relevant pages. Please note that external links to other websites have been restricted to comply with UK pharmaceutical industry guidelines.
Sponsored by Shire Human Genetic Therapies, a business unit of Shire Pharmaceuticals Group Ltd.
Registered in England 5492592
Registered Office: Hampshire International Business Park, Chineham, Basingstoke, Hampshire RG24 8EP.
email: medinfouk@shire.com